Clinical Trials Directory

Trials / Recruiting

RecruitingNCT06600529

Combined Photo-Biomodulation At Acupuncture Points, Autologous PRP, and Umbilical Cord-Derived Exosome Therapy in Autism Spectrum Disorder

Evaluation of Combined Photo-Biomodulation At Acupuncture Points, Autologous PRP, and Umbilical Cord-Derived Exosome Therapy in Autism Spectrum Disorder: a Randomized Controlled Trial

Status
Recruiting
Phase
N/A
Study type
Interventional
Enrollment
100 (estimated)
Sponsor
Iffat Anwar Medical Complex · Academic / Other
Sex
All
Age
3 Years – 12 Years
Healthy volunteers
Not accepted

Summary

This randomized controlled trial aims to evaluate the efficacy of a combination of photo-biomodulation at acupuncture points, autologous platelet-rich plasma (PRP), and umbilical cord-derived exosome therapy in children with Autism Spectrum Disorder (ASD). The study will compare these interventions against standard care to determine their impact on the severity of autism symptoms, as measured by the Childhood Autism Rating Scale (CARS) and other related markers.

Detailed description

The study involves three main interventions: 1. Photo-Biomodulation (PBM): PBM will be performed once a week using an 810nm, 210mW laser probe for 20 seconds at each selected acupuncture point. 2. Autologous Platelet-Rich Plasma (PRP): PRP will be administered at 0 Day, 15 Day, 30 Day, and at 45th Day ADP-derived autologous PRP. 3. Exosome Therapy: Exosomes derived from umbilical cord tissue will be injected intravenously at laser acupuncture points. The PRP-exosome sessions will be repeated at 15 Days, 6 weeks, 12 weeks, and 24 weeks. The study will run over a period of 6 months, with follow-ups and assessments at each phase. The primary outcome measure will be the change in CARS score, with secondary outcomes including additional ASD markers.

Conditions

Interventions

TypeNameDescription
DEVICEPhoto-BiomodulationApplication at acupuncture points for 20 seconds each week. using 810nm Laser probe
BIOLOGICALAutologous PRPIV injection of Autologous Plasma Rich Platelets (PRP) on Days 0, 15, 30, and 45.
BIOLOGICALExosome TherapyIV injection of Umbilical Cord-Derived Exosomes at laser acupuncture points Umbilical Cord-Derived Exosomes
OTHERStandard Care (in control arm)Routine conventional including Applied Behavioral Analysis (ABA) for Autism Spectrum Disorder (ASD)

Timeline

Start date
2024-08-13
Primary completion
2025-06-10
Completion
2025-12-13
First posted
2024-09-19
Last updated
2024-09-19

Locations

1 site across 1 country: Pakistan

Source: ClinicalTrials.gov record NCT06600529. Inclusion in this directory is not an endorsement.